Thus, this workshop was an important initiative that fostered an exchange of information fundamental to the ultimate adoption of toxicogenomics-based test methods for regulatory decision-making purposes.
The three focus areas include a) biologic validation of toxicogenomics-based test methods for regulatory decision making, b) technical and bioinformatics aspects related to validation, and c) validation issues as they relate to regulatory acceptance and use of toxicogenomics-based test methods.
In consideration of all these related issues, ECVAM and ICCVAM/NICEATM held the first of a planned series of workshops to address the validation principles that lend themselves to toxicogenomics-based test methods, for example, gene expression technologies and associated bioinformatics.
The three focus areas were a) biological validation of toxicogenomics-based test methods for regulatory decision making, b) technical and bioinformatics aspects related to validation, and c) validation issues as they relate to regulatory acceptance and use of toxicogenomics-based test methods.
As a main benefit of the use of more abstract, yet formal, modeling languages, a method for model based test sequence generation for reactive systems on the grounds of Constraint Logic Programming as well as its implementation in the CASE tool AutoFocus is presented.
A novel methodology based on analytical and experimental test methods for predicting coated tool efficiency in milling Inconel 718 and Ti6Al4V by coated cemented carbide inserts is introduced.
Based on the test method for laboratory compaction characteristics of soil [2], fresh mixture in the mold was divided into three layers and compacted with 25 blows of rammer for each layer.
Water extracts were prepared based on modified standard test method for shake extraction of soil with water (ASTM 2006).
Properties of the foam concrete were analyzed for density and compressive strength based on the standard testing methods for physical and mechanical properties (ASTM C495 and ASTM C39).
Thus, this kind of microarrays has several advantages over macroarrays and microarray based testing of patient samples is the method of choice for highly paralleled auto-antibody testing.
This method is also widely used in both individual and population screening studies, and is now the CDC-recommended method of sampling for nucleic acid based testing [ 28].
